| Serial Number | 90431302 |
| Word Mark | ARCE |
| Filing Date | Wednesday, December 30, 2020 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Friday, July 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 14, 2021 |
| Goods and Services | Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological tissue cultures for medical purposes, namely, human blood samples, human allograft tissues, human umbilical cord blood and human induced pluripotent stem cells (iPSCs) from somatic cells; biological tissue cultures for veterinary purposes, namely, animal blood samples, tumors and allograft tissues; blood for medical purposes; cultures of microorganisms for medical or veterinary use; diagnostic biomarker reagents for medical purposes, namely, chemical and biological reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceuticals, namely, drugs for medical purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; enzymes for medical purposes; enzymes for veterinary purposes; immunostimulants; medicinal infusions for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for human purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for veterinary purposes, namely, for veterinary cancers; preparations of microorganisms for medical or veterinary use, namely, cultures of bacteria and viruses for medical or veterinary use; pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceutical preparations, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals in the nature of pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; transplants comprised of living cells, namely, genetically engineered tissues for medical and transplant purposes; genetically engineered cells for medical purposes, specifically for transplantation purposes; vaccines |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 24, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ARCE THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 11492 TW |
| Party Name | ARCE THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 11492 TW |
| Event Date | Event Description |
| Saturday, January 2, 2021 | NEW APPLICATION ENTERED |
| Wednesday, March 24, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 6, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, July 1, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, July 6, 2021 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 6, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 10, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 7, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, November 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 14, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 23, 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, August 2, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 20, 2022 | DIVISIONAL REQUEST RECEIVED |
| Thursday, October 20, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, November 2, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, November 3, 2022 | DIVISIONAL PROCESSING COMPLETE |
| Friday, November 18, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, November 4, 2022 | CORRECTED NOA E-MAILED |
| Friday, November 18, 2022 | SOU EXTENSION 1 FILED |
| Friday, November 18, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, July 27, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 27, 2023 | SOU EXTENSION 2 FILED |
| Thursday, July 27, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, July 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 19, 2024 | SOU EXTENSION 4 GRANTED |
| Friday, July 19, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, July 29, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 31, 2024 | SOU EXTENSION 3 FILED |
| Wednesday, January 31, 2024 | SOU EXTENSION 3 GRANTED |
| Friday, February 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |